473 related articles for article (PubMed ID: 31236199)
1. Clinical efficacy of gemcitabine and cisplatin-based transcatheter arterial chemoembolization combined with radiotherapy in hilar cholangiocarcinoma.
Zheng WH; Yu T; Luo YH; Wang Y; Liu YF; Hua XD; Lin J; Ma ZH; Ai FL; Wang TL
World J Gastrointest Oncol; 2019 Jun; 11(6):489-498. PubMed ID: 31236199
[TBL] [Abstract][Full Text] [Related]
2. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.
Isayama H; Tsujino T; Nakai Y; Sasaki T; Nakagawa K; Yamashita H; Aoki T; Koike K
World J Gastroenterol; 2012 May; 18(19):2364-70. PubMed ID: 22654427
[TBL] [Abstract][Full Text] [Related]
3. Novel brachytherapy drainage tube loaded with double
Lei QY; Jiao DC; Han XW
World J Clin Cases; 2020 Oct; 8(19):4603-4608. PubMed ID: 33083424
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic stenting for hilar cholangiocarcinoma: efficacy of unilateral and bilateral placement of plastic and metal stents in a retrospective review of 480 patients.
Liberato MJ; Canena JM
BMC Gastroenterol; 2012 Aug; 12():103. PubMed ID: 22873816
[TBL] [Abstract][Full Text] [Related]
5. [Effects of preoperative percutaneous transhepatic biliary drainage on surgical treatment of type Ⅲ and Ⅳ hilar cholangiocarcinoma].
Wang DD; Xu JZ; Fu Q; Fu XJ; Chen FF; Lu Z; Guo J; Ma X; Sun WL; Zhang DY
Zhonghua Wai Ke Za Zhi; 2019 Apr; 57(4):288-292. PubMed ID: 30929375
[No Abstract] [Full Text] [Related]
6. Surgical procedure and prognosis of hilar cholangiocarcinoma.
Yi B; Zhang BH; Zhang YJ; Jiang XQ; Zhang BH; Yu WL; Chen QB; Wu MC
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):453-7. PubMed ID: 15313688
[TBL] [Abstract][Full Text] [Related]
7. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach.
Paik WH; Park YS; Hwang JH; Lee SH; Yoon CJ; Kang SG; Lee JK; Ryu JK; Kim YT; Yoon YB
Gastrointest Endosc; 2009 Jan; 69(1):55-62. PubMed ID: 18657806
[TBL] [Abstract][Full Text] [Related]
8. Biliary stent combined with iodine-125 seed strand implantation in malignant obstructive jaundice.
Wang HW; Li XJ; Li SJ; Lu JR; He DF
World J Clin Cases; 2021 Feb; 9(4):801-811. PubMed ID: 33585626
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous stent-in-stent placement with large cell-type stents for malignant hilar biliary obstruction.
Kim GH; Gwon DI; Ko GY; Kim JH; Kim JW; Chu HH; Yoon HK; Sung KB
Acta Radiol; 2021 Dec; 62(12):1625-1631. PubMed ID: 33307712
[TBL] [Abstract][Full Text] [Related]
10. Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents.
Freeman ML; Overby C
Gastrointest Endosc; 2003 Jul; 58(1):41-9. PubMed ID: 12838219
[TBL] [Abstract][Full Text] [Related]
11. Combined T/Y biliary stent placement for the treatment of biliary obstruction caused by Bismuth-Corlett type IV hilar cholangiocarcinoma.
Li TF; Li Z; Han XW; Ren JZ; Jiao C; Bi YH; Ren KW
Hepatogastroenterology; 2014 Sep; 61(134):1519-22. PubMed ID: 25436335
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of the relation between surgery and prognosis of hilar cholangiocarcinoma].
Yi B; Zhang BH; Zhang YJ; Jiang XQ; Zhang BH; Yu WL; Cheng QB; Wu MC
Zhonghua Wai Ke Za Zhi; 2005 Jul; 43(13):842-5. PubMed ID: 16083598
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous Metallic Stent Placement for Palliative Management of Malignant Biliary Hilar Obstruction.
Shim DJ; Gwon DI; Han K; Kim Y; Ko GY; Shin JH; Ko HK; Kim JH; Kim JW; Yoon HK; Sung KB
Korean J Radiol; 2018; 19(4):597-605. PubMed ID: 29962866
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome in patients with hilar malignant strictures type II Bismuth-Corlette treated by minimally invasive unilateral versus bilateral endoscopic biliary drainage.
Bulajic M; Panic N; Radunovic M; Scepanovic R; Perunovic R; Stevanovic P; Ille T; Zilli M; Bulajic M
Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):209-14. PubMed ID: 22484591
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous biliary stenting combined with radiotherapy as a treatment for unresectable hilar cholangiocarcinoma.
Tan Y; Zhu JY; Qiu BA; Xia NX; Wang JH
Oncol Lett; 2015 Oct; 10(4):2537-2542. PubMed ID: 26622885
[TBL] [Abstract][Full Text] [Related]
16. Length and quality of survival following external beam radiotherapy combined with expandable metallic stent for unresectable hilar cholangiocarcinoma.
Shinchi H; Takao S; Nishida H; Aikou T
J Surg Oncol; 2000 Oct; 75(2):89-94. PubMed ID: 11064386
[TBL] [Abstract][Full Text] [Related]
17. Primary Clinical Application of Y-Shaped Jogged Stent Implantation in Patients with Malignant Hilar Biliary Obstruction.
Zhao Z; Song J; Fan X; Fang S; Chen M; Chen W; Wu F; Zheng L; Tu J; Ji J
J Gastrointest Surg; 2019 Apr; 23(4):745-750. PubMed ID: 30790219
[TBL] [Abstract][Full Text] [Related]
18. Stage of hilar cholangiocarcinoma predicts recurrence of biliary obstruction in patients with metal stents.
Siddiqui A; Shahid H; Sarkar A; Cox K; Kowalski TE; Loren DE; Sharma A; Laing P; Birch M; Adler DG
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1169-73. PubMed ID: 23811239
[TBL] [Abstract][Full Text] [Related]
19. Effect of percutaneous transhepatic cholangial drainag + radiofrequency ablation combined with biliary stent implantation on the liver function of patients with cholangiocarcinoma complicated with malignant obstructive jaundice.
Qi S; Yan H
Am J Transl Res; 2021; 13(3):1817-1824. PubMed ID: 33841706
[TBL] [Abstract][Full Text] [Related]
20. Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience.
Gusani NJ; Balaa FK; Steel JL; Geller DA; Marsh JW; Zajko AB; Carr BI; Gamblin TC
J Gastrointest Surg; 2008 Jan; 12(1):129-37. PubMed ID: 17851723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
